Virtus ETF Advisers’s Dianthus Therapeutics DNTH Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q1 | – | Sell |
-3,025
| Closed | -$65.9K | – | 388 |
|
2024
Q4 | $65.9K | Sell |
3,025
-397
| -12% | -$8.66K | 0.03% | 413 |
|
2024
Q3 | $93.7K | Buy |
3,422
+64
| +2% | +$1.75K | 0.04% | 386 |
|
2024
Q2 | $86.9K | Buy |
+3,358
| New | +$86.9K | 0.04% | 375 |
|
2021
Q4 | – | Sell |
-1,169
| Closed | -$136K | – | 385 |
|
2021
Q3 | $136K | Sell |
1,169
-61
| -5% | -$7.1K | 0.06% | 356 |
|
2021
Q2 | $192K | Buy |
+1,230
| New | +$192K | 0.08% | 366 |
|
2019
Q4 | – | Sell |
-1,100
| Closed | -$181K | – | 469 |
|
2019
Q3 | $181K | Sell |
1,100
-61
| -5% | -$10K | 0.04% | 263 |
|
2019
Q2 | $274K | Buy |
+1,161
| New | +$274K | 0.06% | 257 |
|